SSA
PFE icon

Schonfeld Strategic Advisors’s Pfizer PFE Stock Holding History

Schonfeld Strategic Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-150,000
Closed -$3.73M – 2565
2025
Q4 		$3.73M Sell
150,000
-899,000
-86% -$22.7M 0.02% 649
2025
Q3 		$26.7M Buy
+1,049,000
New +$25.9M 0.15% 127
2024
Q4 		– Sell
-4,100
Closed -$119K – 2295
2024
Q3 		$119K Sell
4,100
-145,900
-97% -$4.26M ﹤0.01% 1860
2024
Q2 		$4.2M Hold
150,000
– – 0.03% 611
2024
Q1 		$4.16M Buy
+150,000
New +$4.16M 0.03% 720
2023
Q4 		– Sell
-163,800
Closed -$5.43M – 2143
2023
Q3 		$5.43M Buy
+163,800
New +$5.79M 0.04% 522

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Schonfeld Strategic Advisors's PFE Position: Q4 2025 in Review

Schonfeld Strategic Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 501,279 shares — an estimated $12.6M sold.

Schonfeld Strategic Advisors first reported a position in PFE in Q1 2016 and held it in 29 quarters. The position peaked at $39.6M in Q1 2024. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Schonfeld Strategic Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 501,279 Pfizer shares in Q4 2025, an estimated $12.6M.
  • Schonfeld Strategic Advisors first reported a position in Pfizer in Q1 2016 and held it in 29 quarters.
  • Schonfeld Strategic Advisors's Pfizer position peaked at $39.6M in Q1 2024.
  • 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.